Complete Market Analysis and Revenue Forecast of U.S. Microfluidics/Lab-On-A-Chip Markets.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c45806) has announced the addition of "U.S. Microfluidics/Lab-on-a-chip Markets" to their offering. This Frost & Sullivan research service entitled U.S. Microfluidics/Lab-on-a-chip Markets provides a complete market analysis and revenue forecast. In this research, Frost & Sullivans expert analysts thoroughly examine the following markets: DNA/RNA, and protein and cell-based microfluidics. Market Sectors Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this analysis: - DNA/RNA - Protein - Cell Market Overview Microfluidics technology has gained importance in the healthcare business with response to the immense growth in the areas of genomics, high-throughput screening High-throughput screening (HTS), is a method for scientific experimentation especially used in drug discovery and relevant to the fields of biology and chemistry. Purpose and method of drug targets, and lead compounds. The broad spectrum of microfluidics technology essentially provides a backbone for genomics-based drug discovery. Furthermore, the technology can be applied to clinical diagnostics, proteomics, glycomics, cell manipulation, tissue engineering, structural biology Structural biology is a branch of molecular biology concerned with the study of the architecture and shape of biological macromolecules—proteins and nucleic acids in particular—and what causes them to have the structures they have. , combinatorial chemistry Combinatorial chemistry involves the rapid synthesis or the computer simulation of a large number of different but structurally related molecules. Introduction Synthesis of molecules in a combinatorial fashion can quickly lead to large numbers of molecules. , environmental monitoring, and drug delivery markets. The advent of miniaturization min·i·a·tur·ize tr.v. min·i·a·tur·ized, min·i·a·tur·iz·ing, min·i·a·tur·iz·es To plan or make on a greatly reduced scale. min is driving the need for microfluidics technologies. The major barrier for adoption of microfluidics technologies resides in competing traditional technologies. This research service evaluates the current state of the life science microfluidics/lab-on-a-chip markets within the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . The research service identifies key challenges facing the industry and strategies to overcome such obstacles. In addition, market drivers, restraints, trends, market size and potential, and product analysis are provided. The revenue forecast for the microfluidics/lab-on-a-chip market is determined for the period from 2006 to 2012, with the base year of 2005. Related technologies, which are not included in the scope of this study, include bioMEMS, biosensors, microreactors, and microarrays. The microfluidics/lab-on-a-chip markets are segmented by DNA/RNA, protein, cell, and all other applications that fall into the "other" category. The DNA/RNA market segment includes genotyping Genotyping refers to the process of determining the genotype of an individual with a biological assay. Current methods of doing this include PCR, DNA sequencing, and hybridization to DNA microarrays or beads. , DNA/RNA electrophoresis and quantitation, gene expression profiling Microarray technology is often used for gene expression profiling. It makes use of the sequence resources created by the genome sequencing projects and other sequencing efforts to answer the question, , DNA/RNA amplification, DNA sequencing DNA sequencing The determination of the sequence of nucleotides in a sample of DNA. , and DNA/RNA sample preparation. The protein market segment includes protein electrophoresis Protein Electrophoresis Definition Electrophoresis is a technique used to separate different elements (fractions) of a blood sample into individual components. , proteomics sample preparation/ionization, protein expression profiling, protein interactions, and structural biology (protein crystallization/optimization/promotion). The cell market segment includes cell manipulation/lysis/cytometry/electrophysiology, and cell culture/microbiology. Topics Covered: -Scope and Segmentation -Research Methodology -Market Engineering Analysis -Competitive Analysis -Frost and Sullivan Awards For more information visit http://www.researchandmarkets.com/reports/c45806 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion